Skip to main content
TipRanks
Go Ultimate75% OFF

cbdMD (YCBD) Stock Price & Analysis

431 Followers

YCBD Stock Chart & Stats

$0.36-$0.01(-2.94%)
At close: 4:00 PM EST
$0.35$0.4$0.45$0.5Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.34 - $0.37
52-Week Range
$0.33 - $2.56
Previous Close
$0.37
Volume
N/A
Average Volume (3M)
147.29K
Market Cap
$4.19M
Enterprise Value
$7.24M
Total Cash (Recent Filing)
$2.12M
Total Debt (Recent Filing)
$2.21M
Price to Earnings (P/E)
―
Beta
1.35
Next Earnings
Dec 18, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Wholesale Growth

Strong quarterly and year-to-date sales growth, together with faster wholesale expansion, indicates improving distribution and customer reach. A larger wholesale contribution can broaden revenue sources and provide a more scalable foundation for growth over the coming quarters.

Cost Reduction Program

The implemented rightsizing program provides a defined path to reduce recurring cash expenses through payroll, lease, vendor, and supply-chain actions. If realized, these savings could lower cash burn, improve adjusted EBITDA, and move the company closer to breakeven.

Diversification Through Twinlab Acquisition

Adding Twinlab, Reserveage, Metabolife, and ResVitale expands cbdMD beyond hemp-derived products into established wellness categories. This broader portfolio can diversify revenue, improve channel reach, and reduce exposure to a single regulatory framework.

Bears Say

Persistent Losses And Cash Burn

Deeply negative operating and free cash flow show that the business is not currently self-funding its operations. Continued cash burn can constrain investment capacity and increase reliance on financing or balance-sheet resources until profitability becomes consistent.

Margin Compression And Operating Losses

Lower gross margins combined with a wider operating loss indicate that revenue growth is not yet translating proportionally into profitability. Wholesale mix, regulatory rework, and higher expenses may continue to limit earnings conversion while the company scales.

Hemp Regulatory Exposure

Potential changes to the federal hemp definition and THC limits could affect parts of cbdMD’s existing product portfolio and distribution model. Uncertain timing and outcomes make compliance costs, product eligibility, and revenue continuity difficult to plan.

cbdMD News

YCBD FAQ

What was cbdMD’s price range in the past 12 months?
cbdMD lowest stock price was $0.33 and its highest was $2.56 in the past 12 months.
What is cbdMD’s market cap?
cbdMD’s market cap is $4.19M.
When is cbdMD’s upcoming earnings report date?
cbdMD’s next earnings report is estimated for Dec 18, 2026 (not yet confirmed), which is in 31 days.
How were cbdMD’s earnings last quarter?
cbdMD released its earnings results on Aug 13, 2026. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.03 by -$0.08.
Is cbdMD overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does cbdMD pay dividends?
cbdMD does not currently pay dividends.
What is cbdMD’s EPS estimate?
cbdMD’s EPS estimate is -0.09.
How many shares outstanding does cbdMD have?
cbdMD has 11,205,045 shares outstanding.
What happened to cbdMD’s price movement after its last earnings report?
cbdMD reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.03. Following the earnings report the stock price went down -12.389%.
Which hedge fund is a major shareholder of cbdMD?
Hedge funds hold cbdMD shares: the largest hedge-fund position in cbdMD is 71,888,687 shares.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology